SIMILAR PATTERNS OF AMINO ACIDS FOR 5LSU_B_SAMB1304_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 7 | ARG A 159GLY A 160TRP A 161TYR A 204HIS A 242CYH A 308LEU A 317 | NoneSAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-4.0A)SAH A 319 (-4.3A) ZN A 4 (-2.2A)SAH A 319 (-3.9A) | 0.66A | 5lsuB-1pegA:20.5 | 5lsuB-1pegA:28.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rvk | ISOMERASE/LACTONIZING ENZYME (Agrobacteriumfabrum) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | GLY A 288PHE A 51HIS A 317ARG A 78LEU A 367 | None | 1.33A | 5lsuB-1rvkA:undetectable | 5lsuB-1rvkA:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ven | BETA-AMYLASE (Bacillus cereus) |
PF00686(CBM_20)PF01373(Glyco_hydro_14) | 5 | GLY A 250TYR A 211ASN A 218THR A 223LEU A 225 | None | 1.45A | 5lsuB-1venA:undetectable | 5lsuB-1venA:19.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | ARG A 150GLY A 149HIS A 220THR A 285CYH A 289LEU A 298 | NoneNoneSAM A 304 (-4.9A)None ZN A 300 ( 2.3A)SAM A 304 (-4.7A) | 1.27A | 5lsuB-2r3aA:20.3 | 5lsuB-2r3aA:28.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 8 | ARG A 150GLY A 151TRP A 152TYR A 193HIS A 220THR A 285CYH A 289LEU A 298 | NoneSAM A 304 (-3.5A)NoneSAM A 304 (-4.2A)SAM A 304 (-4.9A)None ZN A 300 ( 2.3A)SAM A 304 (-4.7A) | 0.61A | 5lsuB-2r3aA:20.3 | 5lsuB-2r3aA:28.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | HIS A 220ASN A 299THR A 285CYH A 289LEU A 298 | SAM A 304 (-4.9A)NoneNone ZN A 300 ( 2.3A)SAM A 304 (-4.7A) | 1.41A | 5lsuB-2r3aA:20.3 | 5lsuB-2r3aA:28.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bji | PROTO-ONCOGENE VAV (Homo sapiens) |
PF00130(C1_1)PF00169(PH)PF00621(RhoGEF) | 5 | PHE A 521HIS A 554THR A 527CYH A 532LEU A 536 | None ZN A 1 (-3.2A)None ZN A 1 (-2.2A)None | 1.24A | 5lsuB-3bjiA:undetectable | 5lsuB-3bjiA:19.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 136TRP A 137TYR A 178HIS A 210CYH A 275LEU A 284 | SAH A 305 (-3.8A)NoneSAH A 305 (-4.0A)None ZN A 304 ( 2.3A)SAH A 305 (-4.5A) | 0.63A | 5lsuB-3bo5A:21.5 | 5lsuB-3bo5A:27.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 138TYR A 178HIS A 210CYH A 275LEU A 284 | NoneSAH A 305 (-4.0A)None ZN A 304 ( 2.3A)SAH A 305 (-4.5A) | 1.13A | 5lsuB-3bo5A:21.5 | 5lsuB-3bo5A:27.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kvn | ESTERASE ESTA (Pseudomonasaeruginosa) |
no annotation | 5 | GLY X 256PHE X 259HIS X 289ASN X 285THR X 291 | NoneNoneC8E X 623 (-4.4A)NoneNone | 1.38A | 5lsuB-3kvnX:undetectable | 5lsuB-3kvnX:17.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 10 | ARG A 101GLY A 102TRP A 103PHE A 145TYR A 146HIS A 170ASN A 214THR A 217CYH A 221LEU A 230 | SO4 A 235 ( 4.0A)SAM A 237 ( 3.7A)NoneNoneSAM A 237 (-4.1A)SAM A 237 (-4.7A)SAM A 237 (-2.6A)None ZN A 232 (-2.3A)SAM A 237 (-4.8A) | 0.90A | 5lsuB-3ooiA:32.5 | 5lsuB-3ooiA:72.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 5 | TRP A 103PHE A 145TYR A 146ASN A 214CYH A 171 | NoneNoneSAM A 237 (-4.1A)SAM A 237 (-2.6A)None | 1.46A | 5lsuB-3ooiA:32.5 | 5lsuB-3ooiA:72.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 5 | GLY A2151TRP A2152TYR A2194HIS A2218CYH A2270 | SAM A 7 (-3.4A)NoneSAM A 7 (-3.4A)None ZN A 1 (-2.7A) | 0.51A | 5lsuB-3opeA:26.0 | 5lsuB-3opeA:36.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qvn | MANGANESE-CONTAININGSUPEROXIDE DISMUTASE (Candidaalbicans) |
PF00081(Sod_Fe_N)PF02777(Sod_Fe_C) | 5 | GLY A 133TRP A 172TYR A 187ASN A 123THR A 122 | None | 1.03A | 5lsuB-3qvnA:undetectable | 5lsuB-3qvnA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qwt | PUTATIVE GH105FAMILY PROTEIN (Salmonellaenterica) |
PF07470(Glyco_hydro_88) | 5 | GLY A 230TRP A 233HIS A 212PHE A 222ASN A 221 | None | 1.50A | 5lsuB-3qwtA:undetectable | 5lsuB-3qwtA:20.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tvi | ASPARTOKINASE (Clostridiumacetobutylicum) |
PF00696(AA_kinase)PF01842(ACT) | 5 | GLY A 120PHE A 170TYR A 171THR A 51LEU A 54 | NoneASP A 451 (-3.1A)NoneASP A 451 ( 3.9A)None | 1.48A | 5lsuB-3tviA:undetectable | 5lsuB-3tviA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f6e | SUPEROXIDE DISMUTASE[MN], MITOCHONDRIAL (Saccharomycescerevisiae) |
PF00081(Sod_Fe_N)PF02777(Sod_Fe_C) | 5 | GLY A 132TRP A 170TYR A 185ASN A 122THR A 121 | NoneNoneNoneMLY A 187 ( 4.3A)None | 1.03A | 5lsuB-4f6eA:undetectable | 5lsuB-4f6eA:22.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 7 | GLY A1561TRP A1562HIS A1603TYR A1605HIS A1629CYH A1680LEU A1689 | 0UM A1804 (-3.5A)None0UM A1804 (-3.7A)0UM A1804 (-4.2A)None ZN A1803 (-2.2A)0UM A1804 (-4.8A) | 0.73A | 5lsuB-4fmuA:25.1 | 5lsuB-4fmuA:40.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k2u | ANTIBODY HEAVY CHAINANTIBODY LIGHT CHAIN (Mus musculus;Mus musculus) |
PF07654(C1-set)PF07686(V-set)PF07654(C1-set)PF07686(V-set) | 5 | GLY H 98HIS H 95HIS L 55ARG L 53LEU L 46 | NoneNoneSO4 L 301 (-3.8A)NoneNone | 1.38A | 5lsuB-4k2uH:undetectable | 5lsuB-4k2uH:18.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lns | ASPARAGINESYNTHETASE A (Trypanosomabrucei) |
PF03590(AsnA) | 5 | GLY A 333PHE A 325ASN A 262THR A 264LEU A 265 | None | 1.23A | 5lsuB-4lnsA:undetectable | 5lsuB-4lnsA:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 6 | GLY A 457TRP A 458TYR A 493HIS A 552CYH A 614LEU A 623 | SAH A 801 (-3.6A)SAH A 801 (-4.9A)SAH A 801 (-4.0A)None ZN A 805 ( 2.4A)None | 0.71A | 5lsuB-4qeoA:18.2 | 5lsuB-4qeoA:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r33 | NOSL (Streptomycesactuosus) |
PF06968(BATS) | 5 | GLY A 337HIS A 84TYR A 173THR A 277CYH A 313 | NoneGOL A 504 (-4.2A)GOL A 504 (-4.6A)NoneNone | 1.48A | 5lsuB-4r33A:undetectable | 5lsuB-4r33A:22.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r5o | QUINONPROTEINALCOHOLDEHYDROGENASE-LIKEPROTEIN (Bacteroidesthetaiotaomicron) |
PF16819(DUF5074)PF16820(PKD_3) | 5 | ARG A 227GLY A 225TYR A 248ASN A 166LEU A 177 | NoneNone7PE A 503 (-4.6A)7PE A 503 (-4.3A)None | 1.26A | 5lsuB-4r5oA:undetectable | 5lsuB-4r5oA:20.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fmf | RNA POLYMERASE IIPRE-INITIATIONCOMPLEX, TFG1TRANSCRIPTIONINITIATION FACTORIIF SUBUNIT BETA,TFG2 (Saccharomycescerevisiae;Saccharomycescerevisiae) |
PF05793(TFIIF_alpha)PF02270(TFIIF_beta) | 5 | HIS U 117TYR U 393THR V 212ARG V 63LEU V 59 | None | 1.48A | 5lsuB-5fmfU:undetectable | 5lsuB-5fmfU:16.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 11 | ARG A1073GLY A1074TRP A1075HIS A1116PHE A1117TYR A1118HIS A1142ASN A1186THR A1189CYH A1193LEU A1202 | NoneSAM A1304 ( 3.2A)NoneSAM A1304 (-3.4A)NoneSAM A1304 (-3.8A)SAM A1304 (-4.6A)SAM A1304 (-3.6A)SAM A1304 ( 3.9A) ZN A1301 (-2.3A)SAM A1304 ( 4.7A) | 0.40A | 5lsuB-5lsuA:36.4 | 5lsuB-5lsuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 7 | GLY A1074TRP A1075HIS A1116TYR A1118HIS A1142ARG A1192CYH A1193 | SAM A1304 ( 3.2A)NoneSAM A1304 (-3.4A)SAM A1304 (-3.8A)SAM A1304 (-4.6A)None ZN A1301 (-2.3A) | 0.90A | 5lsuB-5lsuA:36.4 | 5lsuB-5lsuA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t9g | GLYCOSIDE HYDROLASE (Bacteroidesuniformis) |
PF00703(Glyco_hydro_2)PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N)PF16355(DUF4982) | 5 | ARG A 589GLY A 585HIS A 798ASN A 800LEU A 799 | None | 1.33A | 5lsuB-5t9gA:undetectable | 5lsuB-5t9gA:17.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1049TRP A1050TYR A1085HIS A1113CYH A1170 | SAM A1505 ( 3.9A)NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A) ZN A1504 (-2.2A) | 0.39A | 5lsuB-5tuyA:19.5 | 5lsuB-5tuyA:28.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1137TRP A1138TYR A1173HIS A1201CYH A1258 | SAM A3001 (-3.6A)NoneSAM A3001 (-4.0A)SAM A3001 (-4.6A) ZN A3005 (-2.3A) | 0.43A | 5lsuB-5vsdA:19.9 | 5lsuB-5vsdA:26.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 9 | ARG A1155GLY A1156TRP A1157PHE A1199TYR A1200HIS A1224THR A1271CYH A1275LEU A1284 | NoneSAM A1301 (-3.6A)NoneNoneSAM A1301 (-3.9A)NoneNone ZN A1304 (-2.3A)SAM A1301 (-4.6A) | 0.78A | 5lsuB-6cenA:31.7 | 5lsuB-6cenA:77.49 |